Novavax Inc (NVAX)
7.21
-0.56
(-7.21%)
USD |
NASDAQ |
Nov 14, 16:00
7.15
-0.06
(-0.83%)
After-Hours: 20:00
Novavax Cash and Short Term Investments (Quarterly): 1.050B for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.050B |
| March 31, 2024 | 480.59M |
| December 31, 2023 | 568.50M |
| September 30, 2023 | 651.10M |
| June 30, 2023 | 505.91M |
| March 31, 2023 | 624.95M |
| December 31, 2022 | 1.337B |
| September 30, 2022 | 1.281B |
| June 30, 2022 | 1.376B |
| March 31, 2022 | 1.571B |
| December 31, 2021 | 1.515B |
| September 30, 2021 | 1.937B |
| June 30, 2021 | 2.075B |
| March 31, 2021 | 1.998B |
| December 31, 2020 | 711.05M |
| September 30, 2020 | 504.03M |
| June 30, 2020 | 502.30M |
| March 31, 2020 | 237.36M |
| December 31, 2019 | 78.82M |
| September 30, 2019 | 71.17M |
| June 30, 2019 | 72.00M |
| March 31, 2019 | 100.20M |
| December 31, 2018 | 92.13M |
| September 30, 2018 | 127.11M |
| June 30, 2018 | 167.11M |
| Date | Value |
|---|---|
| March 31, 2018 | 143.76M |
| December 31, 2017 | 157.30M |
| September 30, 2017 | 172.57M |
| June 30, 2017 | 187.31M |
| March 31, 2017 | 211.18M |
| December 31, 2016 | 235.48M |
| September 30, 2016 | 300.28M |
| June 30, 2016 | 366.36M |
| March 31, 2016 | 433.87M |
| December 31, 2015 | 230.66M |
| September 30, 2015 | 290.19M |
| June 30, 2015 | 314.94M |
| March 31, 2015 | 327.74M |
| December 31, 2014 | 168.06M |
| September 30, 2014 | 178.09M |
| June 30, 2014 | 152.46M |
| March 31, 2014 | 112.83M |
| December 31, 2013 | 133.07M |
| September 30, 2013 | 146.41M |
| June 30, 2013 | 40.60M |
| March 31, 2013 | 44.28M |
| December 31, 2012 | 44.11M |
| September 30, 2012 | 28.41M |
| June 30, 2012 | 26.54M |
| March 31, 2012 | 20.72M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
78.82M
Minimum
Dec 2019
2.075B
Maximum
Jun 2021
1.000B
Average
711.05M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Pfizer Inc | 9.952B |
| Moderna Inc | 6.867B |
| Baxter International Inc | 2.095B |
| Inovio Pharmaceuticals Inc | 110.42M |
| AIM ImmunoTech Inc | 10.06M |